EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Towards Effective Antiviral Oral Therapy: Development of a Novel Self-Double Emulsifying Drug Delivery System for Improved Zanamivir Intestinal Permeability

Sapir Ifrah iD, Arik Dahan iD, Nir Debotton

Pharmaceutics · 23.10.2023 · 15 (10) · 2518

DOI: 10.3390/pharmaceutics15102518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 23.10.2023. Verfasst von Sapir Ifrah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Self-double emulsifying drug delivery systems have the potential to enhance the intestinal permeability of drugs classified under the Biopharmaceutics Classification System (BCS) class III. One such example is the antiviral agent zanamivir, exhibiting suboptimal oral absorption (with a bioavailability range of 1–5%). To address this challenge, we have developed an innovative oral formulation for zanamivir: a self-double nanoemulsifying Winsor delivery system (SDNE-WDS) consisting of the microemulsion, which subsequently yields final double nanoemulsion (W1/O/W2) upon interaction with water. Two distinct formulations were prepared: SDNE-WDS1, classified as a W/O microemulsion, and SDNE-WDS2, discovered to be a bicontinuous microemulsion. The inner microemulsions displayed a consistent radius of gyration, with an average size of 35.1 ± 2.1 nm. Following self-emulsification, the resultant zanamivir-loaded nanoemulsion droplets for zSDNE-WDS1 and zSDNE-WDS2 measured 542.1 ± 36.1 and 174.4 ± 3.4 nm, respectively. Both types of emulsions demonstrated the ability to enhance the transport of zanamivir across a parallel artificial membrane. Additionally, in situ rat intestinal perfusion studies involving drug-loaded SDNE-WDSs revealed a significantly increased permeability of zanamivir through the small intestinal wall. Notably, both SDNE-WDS formulations exhibited effective permeability (Peff) values that were 3.5–5.5-fold higher than those of the low/high permeability boundary marker metoprolol. This research emphasizes the success of SDNE-WDSs in overcoming intestinal permeability barriers and enabling the effective oral administration of zanamivir. These findings hold promise for advancing the development of efficacious oral administration of BCS class III drugs.

Schlagwörter

Stichwörter der Autor:innen

bioavailabilityintestinal permeabilitymicroemulsionnanoemulsionoral drug absorptionself-double emulsifying drug delivery systemzanamivir

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
  • Department of Chemical Engineering, Shenkar College of Engineering and Design, Ramat-Gan 52526, Israel.

ORCID-Profile: Sapir Ifrah, Arik Dahan

Zitieren

APA

Ifrah, S., Dahan, A., & Debotton, N. (2023). Towards Effective Antiviral Oral Therapy: Development of a Novel Self-Double Emulsifying Drug Delivery System for Improved Zanamivir Intestinal Permeability. Pharmaceutics, 15(10), 2518. https://doi.org/10.3390/pharmaceutics15102518

Vancouver

Ifrah S, Dahan A, Debotton N. Towards Effective Antiviral Oral Therapy: Development of a Novel Self-Double Emulsifying Drug Delivery System for Improved Zanamivir Intestinal Permeability. Pharmaceutics. 2023;15(10):2518. doi:10.3390/pharmaceutics15102518

BibTeX
@article{Ifrah2023,
  author = {Ifrah, Sapir and Dahan, Arik and Debotton, Nir},
  title = {Towards Effective Antiviral Oral Therapy: Development of a Novel Self-Double Emulsifying Drug Delivery System for Improved Zanamivir Intestinal Permeability},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {10},
  pages = {2518},
  doi = {10.3390/pharmaceutics15102518}
}
Kostenlos starten →